Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Ovarian Neoplasms and ABCC1[original query] |
---|
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 25 (29): 4528-35. Marsh Sharon, Paul Jim, King Cristi R, Gifford Gillian, McLeod Howard L, Brown Robe |
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. The pharmacogenomics journal 2011 Apr 11 (2): 113-20. Bergmann T K, Brasch-Andersen C, Gréen H, Mirza M, Pedersen R S, Nielsen F, Skougaard K, Wihl J, Keldsen N, Damkier P, Friberg L E, Peterson C, Vach W, Karlsson M O, Brosen |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival. Carcinogenesis 2018 Jul 39 (7): 879-888. Freedman Jennifer A, Wang Yanru, Li Xuechan, Liu Hongliang, Moorman Patricia G, George Daniel J, Lee Norman H, Hyslop Terry, Wei Qingyi, Patierno Steven |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: